Kyverna Therapeutics, Inc.
KYTX
Jodie situation report
Kyverna Therapeutics, Inc.'s move is being confirmed by its market group.
No new filing conclusion is available. 21 of 21 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 5 directly disclosed connections are confirming.
- At least 14 of 21 members remain active in the next snapshot.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as CBLL begins moving with the group.
Invalidation: The live read weakens if participation falls to 7 of 21 members or fewer.
Who this business touches
The relationships behind KYTX
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
NTLAIntellia Therapeutics, Inc.partnerMay 12, 2026 ▾
“In December 2021, we entered into a License and Collaboration Agreement, or the Intellia Agreement, with Intellia Therapeutics, Inc., a clinical-stage biotechnology company focused on developing novel therapeutics leveraging CRISPR-based technologies, or Inte…”
CRSPCRISPR Therapeutics AGcompetitorMay 12, 2026 ▾
“During the term of the Co-Co Agreement, subject to certain exceptions, neither party will clinically develop or commercialize a cell therapy product directed to CD19 other than the CRISPR Product for use in the treatment or prevention of certain indications s…”
Depended on by
IMMXImmix Biopharma, Inc.competitorMar 25, 2026 ▾
“In addition, we face competition from companies developing cell therapies for immune-mediated disease, some of which include Kyverna Therapeutics, Inc.; Cabaletta Bio, Inc.; Fate Therapeutics Inc.; and Arcellx, Inc.”
Filing peers
No filing peers are available for this name yet.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 2 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
KYTX is currently a Early Follower in the organic co-movement group Oncology and Gastrointestinal Biotech. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.